Bortezomib Induction and Maintenance Treatment in Patients With Newly Diagnosed Multiple Myeloma: Results of the Randomized Phase III HOVON-65/GMMG-HD4 Trial

P. Sonneveld, I.G.H. Schmidt-Wolf, B. van der Holt, L. el Jarari, U. Bertsch, H. Salwender, S. Zweegman, E. Vellenga, A. Broyl, I.W. Blau, K.C. Weisel, S. Wittebol, G.M.J. Bos, M. Stevens-Kroef, C. Scheid, M. Pfreundschuh, D. Hose, A. Jauch, H. te Velde, R. RaymakersM.R. Schaafsma, M.J. Kersten, M. van Marwijk-Kooy, U. Duehrsen, W. Lindemann, P.W. Wijermans, H.M. Lokhorst, H.M. Goldschmidt

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)2946-2955
JournalJournal of Clinical Oncology
Volume30
Issue number24
DOIs
Publication statusPublished - 2012

Cite this

Sonneveld, P., Schmidt-Wolf, I. G. H., van der Holt, B., el Jarari, L., Bertsch, U., Salwender, H., ... Goldschmidt, H. M. (2012). Bortezomib Induction and Maintenance Treatment in Patients With Newly Diagnosed Multiple Myeloma: Results of the Randomized Phase III HOVON-65/GMMG-HD4 Trial. Journal of Clinical Oncology, 30(24), 2946-2955. https://doi.org/10.1200/JCO.2011.39.6820